Deformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Type</td><td class="align_center">DNVs</td><td class="align_center">Conventional NVs</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left"><i>Characteristics</i></td><td class="align_center"> </td><td class="align_center"> </td></tr><tr><td class="align_left">Size (diameter)</td><td class="align_center">236 ± 62 nm</td><td class="align_center">204 ± 47 nm</td></tr><tr><td class="align_left">Zeta potential</td><td class="align_center">33.8 ± 3.5 mV</td><td class="align_center">29.2 ± 1.4 mV</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<i>Characteristics of AF647-Zol-loaded DNVs/NVs</i>. AF647-loaded NVs and DNVs were prepared in the microfluidic reactor using the modified method. DNVs were slightly larger in diameter than NVs and also had a greater zeta potential.

Journal of Drug Delivery

tab2

Table 2

Table 2: Deformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery 